Old Web
English
Sign In
Acemap
>
authorDetail
>
K Vanderkerken
K Vanderkerken
Cancer research
Multiple myeloma
Medicine
Amitriptyline
Bortezomib
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AMITRIPTYLINE STRENGTHENS THE EFFECTS OF BORTEZOMIB AND MELPHALAN TREATMENT IN MULTIPLE MYELOMA BY INHIBITING ACID SPHINGOMYELINASE: PS1369
2019
Sylvia Faict
Inge Oudaert
K De Veirman
Ken Maes
L Jacobs
E. De Bruyne
Johannes V. Swinnen
Rik Schots
Karel Fostier
I. Vandebroek
K Vanderkerken
L. DʼAuria
Eline Menu
Show All
Source
Cite
Save
Citations (0)
TARGETING PROTEIN ARGININE METHYLTRANFERASE PRMT5 IN HIGH-RISK MULTIPLE MYELOMA: A NEW TREATMENT STRATEGY?: PF577
2019
Philip Vlummens
Stefaan Verhulst
K De Veirman
Eline Menu
Fritz Offner
K Vanderkerken
Jérôme Moreaux
E. De Bruyne
Ken Maes
Show All
Source
Cite
Save
Citations (0)
Review The role of the bone marrow microenvironment in multiple myeloma
2005
K Vanderkerken
Show All
Source
Cite
Save
Citations (0)
1